Antenatal glucocorticoid therapy accelerates ATP production with creatine kinase increase in the growth-enhanced fetal rat heart

Circulation Journal

Volumn 74, Issue 1, 2010, Pages 171-180

  Mizuno, Masanori ^a   Takeba, Yuko ^a   Matsumoto, Naoki ^a   Tsuzuki, Yoshimitsu ^a   Asoh, Kentaro ^a   Takagi, Masayuki ^a   Kobayashi, Shinichi ^a   Yamamoto, Hitoshi ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ATP; Creatine kinase; Fetus; Glucocorticoid; Heart

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE KINASE; CREATINE KINASE ISOENZYME; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; IODINE DERIVATIVE; MESSENGER RNA; MITOCHONDRIAL CREATINE KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CREATINE KINASE BLOOD LEVEL; FEMALE; FETUS HEART; GENE EXPRESSION REGULATION; GESTATIONAL AGE; HEART CELL CULTURE; HEART DEVELOPMENT; IN VITRO STUDY; MATURATION; NONHUMAN; PREGNANCY; PRENATAL CARE; RAT; SYNTHESIS;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CREATINE KINASE, MB FORM; DEXAMETHASONE; FEMALE; FETAL DEVELOPMENT; GLUCOCORTICOIDS; HEART; MIFEPRISTONE; MODELS, ANIMAL; MYOCARDIUM; MYOCYTES, CARDIAC; PPAR GAMMA; PREGNANCY; RATS; RATS, WISTAR; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER;

EID: 75149146005     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0311     Document Type: Article

References (42)

1. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972; 50: 515-525.
2. Crowley P, Chalmers I, Keirse MJ. The effects of corticosteroid administration before preterm delivery: An overview of the evidence from controlled trials. Br J Obstet Gynaecol 1990; 97: 11-25.
3. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 1995; 273: 413-418.
4. Naeye RL, Harcke HT Jr, Blanc WA. Adrenal gland structure and the development of hyaline membrane disease. Pediatrics 1971; 47: 650-657.
5. Fowden AL, Li J, Forhead AJ. Glucocorticoids and the preparation for life after birth: Are there long-term consequences of the life insurance? Proc Nutr Soc 1998; 57: 113-122.
6. Durham PL, Wohlford-Lenane CL, Snyder JM. Glucocorticoid regulation of surfactant-associated proteins in rabbit fetal lung in vivo. Anat Rec 1993; 237: 365-377.
7. Kluckow M. Low systemic blood flow and pathophysiology of the preterm transitional circulation. Early Hum Dev 2005; 81: 429-437.
8. Grant DA, Hollander E, Skuza EM, Fauchere JC. Interactions between the right ventricle and pulmonary vasculature in the fetus. J Appl Physiol 1999; 87: 1637-1643.
9. Koenen SV, Mecenas CA, Smith GS, Jenkins S, Nathanielsz PW. Effects of maternal betamethasone administration on fetal and maternal blood pressure and heart rate in the baboon at 0.7 of gestation. Am J Obstet Gynecol 2002; 186: 812-817.
10. 2+-dependent nitric oxide synthase activity in rat lung. Pediatr Res 2000; 48: 91-95.
11. Arima M, Kumai T, Asoh K, Takeba Y, Murano K, Goto K, et al. Effects of antenatal dexamethasone on antioxidant enzymes and nitric oxide synthase in the rat lung. J Pharmacol Sci 2008; 106: 242-248.
12. Tsuzuki Y, Takeba Y, Kumai T, Matsumoto N, Asoh K, Murano K, et al. Identification and expression of cardiac contractry protein troponin T by antenatal glucocorticoid therapy in fetal and infant rats. Pediatr Cardiol Card Surg 2007; 24: 35-43.
13. Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev 2000; 80: 1107-1213.
14. Ventura-Clapier R, Garnier A, Veksler V. Energy metabolism in heart failure. J Physiol 2004; 555: 1-13.
15. Dowell RT. Phosphorylcreatine shuttle enzymes during perinatal heart development. Biochem Med Metab Biol 1987; 37: 374-384.
16. Bessman SP, Geiger PJ. Transport of energy in muscle: The phosphorylcreatine shuttle. Science 1981; 211: 448-452.
17. Saupe KW, Spindler M, Tian R, Ingwall JS. Impaired cardiac energetics in mice lacking muscle-specific isoenzymes of creatine kinase. Circ Res 1998; 82: 898-907.
18. Nishimura Y, Inoue T, Morooka T, Node K. Mechanical stretch and angiotensin II increase interleukin-13 production and interleukin-13 receptor α2 expression in rat neonatal cardiomyocytes. Circ J 2002; 72: 647-653.
19. Yamamuro M, Yoshimura M, Nakayama M, Abe K, Sumida H, Sugiyama S, et al. Aldosterone, but angiotensin II, reduces angiotensin converting enzyme 2 gene expression levels in cultured neonatal rat cardiomyocytes. Circ J 2008; 72: 1346-1350.
20. Benmohamed F, Ferron L, Ruchon Y, Gouadon E, Renaud JF, Capuano V. Regulation of T-type Cav3.1 channels expression by synthetic glucocorticoid dexamethasone in neonatal cardiac myocytes. Mol Cell Biochem 2009; 320: 173-183.
21. Eimre M, Paju K, Pelloux S, Beraud N, Roosimaa M, Kadaja L, et al. Distinct organization of energy metabolism in HL-1 cardiac cell line and cardiomyocytes. Biochim Biophys Acta 2008; 1777: 514-524.
22. Pfanner N, Wiedemann N, Meisinger C, Lithgow T. Assembling the mitochondrial outer membrane. Nat Struct Mol Biol 2004; 11: 1044-1048.
23. Xu Y, Agrawal S, Cook TJ, Knipp GT. Maternal di-(2-ethylhexyl)-phthalate exposure influences essential fatty acid homeostasis in rat placenta. Placenta 2008; 29: 962-969.
24. Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, Wahli W. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell 1992; 68: 879-887.
25. Bolt RJ, van Weissenbruch MM, Lafeber HN, Delemarre-van de Waal HA. Glucocorticoids and lung development in the fetus and preterm infant. Pediatr Pulmonol 2001; 32: 76-91.
26. Liggins GC. The role of cortisol in preparing the fetus for birth. Reprod Fertil 1994; 6: 141-150.
27. Challis JR, Sloboda D, Matthews SG, Holloway A, Alfaidy N, Patel FA, et al. The fetal placental hypothalamic-pituitary-adrenal (HPA) axis, parturition and post natal health. Mol Cell Endocrinol 2001; 185: 135-144.
28. Watchko JF, Daood MJ, LaBella JJ. Creatine kinase activity in rat skeletal muscle relates to myosin phenotype during development. Pediatr Res 1996; 40: 53-58.
29. Hoerter JA, Ventura-Clapier R, Kuznetsov A. Compartmentation of creatine kinases during perinatal development of mammalian heart. Mol Cell Biochem 1994; 133-134: 277-286.
30. Ventura-Clapier R, Veksler V, Hoerter JA. Myofibrillar creatine kinase and cardiac contraction. Mol Cell Biochem 1994; 133-134: 125-144.
31. Hoerter JA, Kuznetsov A, Ventura-Clapier R. Functional development of the creatine kinase system in perinatal rabbit heart. Circ Res 1991; 69: 665-676.
32. Ingwall JS, Kramer MF, Woodman D, Friendman WF. Maturation of energy metabolism in the lamb: Changes in myosin ATPase and creatine kinase activities. Pediatr Res 1981; 15: 1128-1133.
33. Montano MM, Lim RW. Glucocorticoid effects on the skeletal muscle differentiation program: Analysis of clonal proliferation, morphological differentiation and the expression of muscle-specific and regulatory genes. Endocr Res 1997; 23: 37-57.
34. Yoshiko Y, Hirao K, Maeda N. Dexamethasone regulates the actions of endogenous insulin-like growth factor-II during myogenic differentiation. Life Sci 1998; 63: 77-85.
35. Tiivel T, Kadaya L, Kuznetsov A, Kaambre T, Peet N, Sikk P, et al. Developmental changes in regulation of mitochondrial respiration by ADP and creatine in rat heart in vivo. Mol Cell Biochem 2000; 208: 119-128.
36. Skulachev VP. Cytochrome c in the apoptotic and antioxidant cascades. FEBS Lett 1998; 423: 275-280.
37. Kroemer G, Zamzami N, Susin SA. Mitochondrial control of apoptosis. Immunol Today 1997; 18: 44-51.
38. Zhivotovsky B, Orrenius S, Brustugun OT, Doskeland SO. Injected cytochrome c induces apoptosis. Nature 1998; 391: 449-450.
39. Bowser DN, Minamikawa T, Nagley P, Williams DA. Role of mitochondria in calcium regulation of spontaneously contracting cardiac muscle cells. Biophys J 1998; 75: 2004-2014.
40. Spindler M, Niebler R, Remkes H, Horn M, Lanz T, Neubauer S. Mitochondrial creatine kinase is critically necessary for normal myocardial high-energy phosphate metabolism. Am J Physiol Heart Circ Physiol 2002; 283: H680-H687.
41. Wu F, Beard DA. Roles of the creatine kinase system and myoglobin in maintaining energetic state in the working heart. BMC Syst Biol 2009; 19: 1-16.
42. Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 1999; 4: 585-595.